Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE987.80-5.5 (-0.55 %)
PREV CLOSE ( ) 993.30
OPEN PRICE ( ) 993.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 163184
TODAY'S LOW / HIGH ( )980.75 1009.55
52 WK LOW / HIGH ( )737.9 1063.75
NSE987.60-6.15 (-0.62 %)
PREV CLOSE( ) 993.75
OPEN PRICE ( ) 994.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 987.60 (3821)
VOLUME 2971468
TODAY'S LOW / HIGH( ) 980.85 1009.50
52 WK LOW / HIGH ( )738.05 1063.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

11Jun Aurobindo Pharma informs about earning
Aurobindo Pharma has informed that it has enclosed the Transcript of the..
11Jun Aurobindo Pharma informs about newspap
Aurobindo Pharmahas informed that it enclosed copies of the notice for t..
31May Aurobindo Pharma informs about reappoi
Aurobindo Pharma has informed that the board of Directors of the Company..
31May Aurobindo Pharma reports 7% fall in Q4
Aurobindo Pharma has reported results for fourth quarter and year ended..
18May Aurobindo Pharma informs about annual
Pursuant to the SEBI circular dated February 08, 2019, Aurobindo Pharma..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit8725.831129.1
Gross Profit 11134.5 41930.1
Operating Profit 12434.547096.8
Net Sales 41140.3158236.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2083.85 (1.39%)
M.Cap ( in Cr)1287.41
Natco Pharma (BSE)
peergroup  1131.25 (2.25%)
M.Cap ( in Cr)20626.97
Orchid Pharma (BSE)
peergroup  1371.50 (1.75%)
M.Cap ( in Cr)5597.97
JB Chem & Pharma (BSE)
peergroup  1526.30 (1.34%)
M.Cap ( in Cr)11795.57
SMS Lifesciences (BSE)
peergroup  646.55 (1.74%)
M.Cap ( in Cr)195.47

Shareholding Pattern

MUTUAL FUNDS/UTI 8.84%
PROMOTERS 51.94%
FI/BANKS/INSURANCE 2.15%
NON-INSTITUTION 10.45%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 987.8. Its current market capitalisation stands at Rs 57879.02 Cr. In the latest quarter, company has reported Gross Sales of Rs. 133097.4 Cr and Total Income of Rs.136698.5 Cr. The company's management includes B Adi Reddy, K Nithyananda Reddy, Savita Mahajan, Avnit Bimal Singh, P V Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)